These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16149454)

  • 1. [Interleukin-3 (IL-3), IL-4, IL-5].
    Niiro H
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():68-71. PubMed ID: 16149454
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interleukin-3(IL-3), IL-4, IL-5].
    Niiro H
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():72-4. PubMed ID: 20960752
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interleukin-3 (IL-3), IL-4, IL-5].
    Asano Y; Niho Y
    Nihon Rinsho; 1999 Nov; 57 Suppl():779-82. PubMed ID: 10635968
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interleukin-11, 12, 13, 14, 15, 16, 17, 18 (IL-11, 12, 13, 14, 15, 16, 17, 18)].
    Maeda T; Nakazato M
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():79-82. PubMed ID: 16149457
    [No Abstract]   [Full Text] [Related]  

  • 5. [Granulocyte-macrophage colony-stimulating factor].
    Kimura F
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():51-3. PubMed ID: 16149449
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluating the profile of selected cytokines in patients with food allergy and chronic gastritis.
    Bartuzi Z; Zbikowska-Gotz M; Romański B; Sinkiewicz W
    Med Sci Monit; 2000; 6(6):1128-35. PubMed ID: 11208468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Important role of interleukin-3 in the early phase of collagen-induced arthritis.
    Brühl H; Cihak J; Niedermeier M; Denzel A; Rodriguez Gomez M; Talke Y; Goebel N; Plachý J; Stangassinger M; Mack M
    Arthritis Rheum; 2009 May; 60(5):1352-61. PubMed ID: 19404955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interleukin-6 (IL-6) /soluble IL-6 receptor].
    Yokoyama A
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():72-4. PubMed ID: 16149455
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma GM-CSF, IL-6, and IL-3 monitoring allows differentiation between infection and rejection in some renal transplant recipients: preliminary results of a retrospective study.
    Daniel V; Pasker S; Reiss U; Weimer R; Wiesel M; Pomer S; Staehler G; Opelz G
    Transplant Proc; 1993 Feb; 25(1 Pt 2):893-6. PubMed ID: 8382882
    [No Abstract]   [Full Text] [Related]  

  • 10. [LIF (leukemia inhibitory factor)].
    Honma Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():123-4. PubMed ID: 16149468
    [No Abstract]   [Full Text] [Related]  

  • 11. [SCF (stem cell factor)].
    Ishiguro A
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():57-9. PubMed ID: 16149451
    [No Abstract]   [Full Text] [Related]  

  • 12. Measurement of mouse and human interleukin 5.
    Harriman GR
    Curr Protoc Immunol; 2001 May; Chapter 6():Unit 6.5. PubMed ID: 18432818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enzyme linked immunosorbent assay for the detection of human interleukin 3 in serum.
    Pauly JU; Heder A; Kurrle R; Seiler FR
    Behring Inst Mitt; 1991 Dec; (90):104-11. PubMed ID: 1801686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dysregulation of cooperative interactions of immunocytes and eosinophils in the mechanism of development of eosinophilia in Opisthorhis felineus invasion].
    Litvinova LS; Riazantseva NV; Novitskiĭ VV
    Med Parazitol (Mosk); 2008; (3):13-7. PubMed ID: 18819423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukins in immunologic and allergic diseases.
    Herrod HG
    Ann Allergy; 1989 Oct; 63(4):269-72. PubMed ID: 2679243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraordinarily high eosinophilia and elevated serum interleukin-5 level observed in a patient infected with Paragonimus westermani.
    Kan H; Ogata T; Taniyama A; Migita M; Matsuda I; Nawa Y
    Pediatrics; 1995 Aug; 96(2 Pt 1):351-4. PubMed ID: 7630699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interleukin-1 (IL-1) alpha, beta, IL-1 receptor, IL-1 receptor antagonist (IL-1ra)].
    Hayashi H; Onozaki K
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():60-4. PubMed ID: 16149452
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of different T cell sublines using either interleukin 2 or interleukin 4 as growth factors.
    Schmitt E; Van Brandwijk R; Fischer HG; Rüde E
    Eur J Immunol; 1990 Aug; 20(8):1709-15. PubMed ID: 2120063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Decay-accelerating factor].
    Negoro T; Nakano Y
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():102-4. PubMed ID: 20942012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.